We investigated the role of mitophagy in NAFLD-related hepatocarcinogenesis by clustering hepatic preneoplastic lesions according to the expression ratios of LC3, AMBRA1, and Parkin, based on a previously established method [34]. The gene discussed is PRKN; the disease is metabolic dysfunction-associated steatotic liver disease.